We hope to see you again soon!

You are now leaving Lundbeck UK's website (www.lundbeck.com/uk) for an external website. External links are provided as a resource to the viewer. Lundbeck UK are not responsible for the external website and its content.

UK-NOTPR-1010 | April 2022



This is Lundbeck

Who We Are

Today, millions of people all over the world live with brain diseases. Every day, at Lundbeck we strive to further understand these diseases, develop innovative therapies to treat them and make a difference to people living with them.

We are one of the only pharmaceutical companies in the world focused exclusively on brain diseases and our speciality sets us apart. Our purpose is clear:

We are tirelessly dedicated to restoring brain health, so every person can be their best.

Driven by research…

For more than 70 years, we’ve been pushing the boundaries of neuroscience. By combining the logic of science with our passion for making a difference to patients, we’ve pioneered some of the most important and commonly used therapies within the antipsychotic and antidepressant markets.


We work closely with patients, healthcare professionals and the neuroscience community to help uncover causes and to find potential new treatments that can bring back quality of life to people living with brain diseases. 

…raising our voice…

As a global specialist, we owe it to those who live with brain diseases to fight stigma and promote improved treatment. That’s why we work to improve understanding and parity of care across communities and societies – so we can empower people and rebuild hope.

…giving profit a purpose…

The Lundbeck Foundation is the majority owner of Lundbeck. Foundation ownership allows us to stay focused on our areas of specialty. It also means that we are in a position to give back. With donations of approximately DKK 500 million a year to biomedical research, the Foundation supports the progress of health science. 

…and working with one aim.

Today, we’re 5,600 people in 50+ countries. We build on our Danish heritage, fostering a culture of collaboration and responsibility. Whether we work in labs or in the field, we all have the same aim: to develop innovative treatments that improve the lives of people living with brain diseases. We call this Progress in Mind. 

Our beliefs

The mindset which governs our behavior in all we do.

  • Patient-Driven
    We put patients at the centre in our fight for health and human dignity.

  • Courageous
    We dare to confront unsolved healthcare challenges.

  • Ambitious
    We set high expectations for ourselves because people in need have high expectations of us.

  • Passionate
    We persist in developing life-changing therapies for people because life should not be interrupted by brain disease.

  • Responsible
    We act with respect and integrity in everything we do.

At a glance

Lundbeck is a global pharmaceutical company specialising in developing innovative treatments for brain diseases. For more than 70 years, millions of people have been treated with our products.

More from Lundbeck

Our Commitment

We strive for Progress in Mind - our multifaceted approach to patients.

Our Science

Lundbeck has developed some of the most widely prescribed therapies for brain diseases.

Life at Lundbeck

5,600 colleagues, 50+ countries, working with one aim.

UK-NOTPR-0499 | April 2022